Yaqiang Huang
-
- Cancer-related molecular mechanisms research 3
- Cancer, Hypoxia, and Metabolism 2
- Cancer, Lipids, and Metabolism 2
- MicroRNA in disease regulation 2
-
- Epigenetics and DNA Methylation 2
-
- Prostate Cancer Treatment and Research 5
- Ferroptosis and cancer prognosis 2
-
- Bladder and Urothelial Cancer Treatments 3
Yaqiang Huang
16 papers receiving 361 citations
Peers
Comparison fields: 5 of 56
- Cancer Research 142
- Molecular Biology 257
- Cell Biology 45
- Pulmonary and Respiratory Medicine 89
- Oncology 48
Countries citing papers authored by Yaqiang Huang
This map shows the geographic impact of Yaqiang Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaqiang Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaqiang Huang more than expected).
Fields of papers citing papers by Yaqiang Huang
This network shows the impact of papers produced by Yaqiang Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaqiang Huang. The network helps show where Yaqiang Huang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yaqiang Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 2 | |
| 5 | 2024 | 7 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 2 | |
| 8 | 2023 | 2 | |
| 9 | 2022 | 12 | |
| 10 | 2021 | 14 | |
| 11 | 2018 | 40 | |
| 12 | 2017 | 20 | |
| 13 | 2015 | 42 | |
| 14 | 2014 | 30 | |
| 15 | 2014 | 15 | |
| 16 | 2014 | 24 | |
| 17 | Clinical performance of serum [-2]proPSA derivatives, %p2PSA and PHI, in the detection and management of prostate cancer. | 2014 | 18 |
| 18 | 2013 | 43 | |
| 19 | 2013 | 89 |
About Yaqiang Huang
Yaqiang Huang is a scholar working on Cancer Research, Urology and Pulmonary and Respiratory Medicine, having authored 19 papers that have together received 362 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (5 papers), Bladder and Urothelial Cancer Treatments (3 papers), Cancer-related molecular mechanisms research (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Epigenetics and DNA Methylation (2 papers), Cancer, Lipids, and Metabolism (2 papers), MicroRNA in disease regulation (2 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Cancer Research (142 citations), Molecular Biology (257 citations) and Cell Biology (45 citations). Yaqiang Huang has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Weide Zhong, Zhaodong Han, Yuxiang Liang, Huichan He, Qi-Shan Dai, Funeng Jiang, Xiaohui Ling, Hongxing Huang, Chin‐Lee Wu and Chao Cai. Their work appears in journals such as Frontiers in Immunology, Medical Oncology, Frontiers in Cell and Developmental Biology, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease and Human Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.